Boardroom Alpha
Boardroom Alpha
BBBY · Additional Proxy Materials (DEFA14A) · Filed April 30, 2026

Bed Bath & Beyond Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
April 30, 2026
Ticker
BBBY
Accession
0001140361-26-017945
Boardroom Alpha · Filing insights

Bed Bath & Beyond recommends voting FOR Item 3; outlines 2026 compensation changes tied to EBITDA and revenue.

Proxy advisor rec.
About Bed Bath & Beyond Inc
Market cap
$478M
1Y TSR
−17.0%
3Y TSR
−37.9%
Board grade
D
Sector
Consumer Cyclical
CEO
Marcus Lemonis
Last annual meeting: May 14, 2026 · View full Bed Bath & Beyond Inc profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.  )

Filed by the Registrant ☒

Filed by a Party other than the Registrant   ☐

Check the appropriate box:

Preliminary Proxy Statement

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

Definitive Proxy Statement

Definitive Additional Materials

Soliciting Material under §240.14a-12

Bed Bath & Beyond, Inc.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

No fee required.

Fee paid previously with preliminary materials.

Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.




Dear Stockholders,
 
The Board of Directors of Bed Bath & Beyond, Inc. is issuing supplemental information to our Proxy Statement filed on March 27, 2026. We recognize that ISS has recommended a vote AGAINST our Say on Pay proposal, citing the Compensation Committee’s responsiveness to last year’s low vote result. The Board is providing additional information concerning our efforts to respond to stockholders following last year’s advisory vote on executive compensation.
 
The Company’s 2025 Say on Pay vote at the May 2025 annual meeting received approximately 68.9% support from our stockholders. Our Board of Directors, Compensation Committee, and management team took this result seriously. Following the annual meeting, the Company undertook targeted stockholder engagement as part of its regular cadence for engaging with investors during customary post-earnings outreach. Members of management, at the direction of the Compensation Committee, extended invitations to engage with stockholders representing more than 40% of our outstanding shares and engaged with stockholders representing approximately 30% of our outstanding shares, including the majority of our largest institutional investors.  Independent members of the Board were available for engagement upon request.
 
Stockholders generally expressed support for the Company’s compensation framework and pay-for-performance philosophy, while also providing constructive feedback regarding incentive design and alignment of realized pay outcomes with performance. However, the Compensation Committee did not receive feedback from stockholders about specific concerns with the compensation program, or reasons behind their voting decisions in 2025. Nevertheless, the Compensation Committee, after consultation with its independent compensation consultant, approved changes to the 2026 compensation program to further strengthen the alignment between executive pay and Company performance above and beyond the changes we implemented in 2024.
 

1.
The Compensation Committee approved changes to the structure of the Company’s 2026 cash bonus program and performance share award design to strengthen the linkage between performance results, particularly revenue growth, and earned compensation. For 2026, both the annual cash bonus program and the performance share awards are tied to Adjusted EBITDA and revenue. Revenue represents a new performance metric, reflecting the Company’s increased focus on top-line growth and ensuring that the compensation earned by our executives moves in direct proportion to the results that matter most to stockholders. This builds on the 2025 program structure that ties a substantial portion of target compensation to performance while sharpening the connection between pay and the financial outcomes stockholders expect us to deliver.
 


2.
The Compensation Committee also took a disciplined approach to target compensation levels for 2026. For executives who continued in the same role year over year, target compensation was held flat, and remained substantially weighted on performance-based pay vehicles. This follows 22% to 48% decreases in grant values in 2025 compared to 2024 as the Compensation Committee referenced market data that used smaller-sized peer companies and shifted the pay targeting approach. We believe this reflects the appropriate balance between retaining and incentivizing a leadership team navigating a complex strategic transformation, and ensuring that the total compensation opportunity is commensurate with what our stockholders should expect us to pay for the performance we are asking our executives to deliver.
 

3.
For the 2026 grants to our CEO and our newly-hired executives, the Compensation Committee moved from a three-year performance period to a four-year performance period for performance share awards, and from a three-year vesting period to a four-year vesting period for time-based RSUs. These performance share awards are eligible to vest over a period of four years, with 25% of the award eligible to vest based on annual performance goals to be established at the beginning of each year during the four-year performance period. The RSUs will vest ratably over a four-year period.
 
The Compensation Committee believes these actions represent meaningful enhancements to our compensation program as informed by our stockholder outreach and appropriately reflect its commitment to align executive compensation with the Company’s long-term strategy and stockholder value creation.
 
We believe that a vote FOR Item 3 is in the best interests of stockholders and reflects a fair assessment of the actions the Compensation Committee has taken to align executive compensation with the Company’s evolving strategic priorities and long-term stockholder value creation.
 
The Compensation Committee and the full Board remain committed to ongoing engagement with our stockholders on compensation matters and welcome continued dialogue.
 
Sincerely,
 
Board of Directors of Bed Bath & Beyond, Inc.
 


From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Bed Bath & Beyond Inc (BBBY)

Reference

Frequently asked questions

When did Bed Bath & Beyond Inc file this DEFA14A?
Bed Bath & Beyond Inc (BBBY) filed this Additional Proxy Materials (DEFA14A) with the SEC on April 30, 2026. The accession number assigned by EDGAR is 0001140361-26-017945.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Bed Bath & Beyond recommends voting FOR Item 3; outlines 2026 compensation changes tied to EBITDA and revenue. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Proxy advisor rec.". It appears above the filing body as a labeled pill.
Where can I find Bed Bath & Beyond Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Bed Bath & Beyond Inc has filed under CIK 1130713, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer